OxSyBio, a UK-based 3D biological materials printing spinout from University of Oxford, received $13.9m in series A funding on Monday from a round that included commercialisation firm IP Group.
Fund manager Woodford Investment Management led the round, which also included spinout-focused investment firm Parkwalk Advisors, a subsidiary of IP Group. OxSyBio will receive part of the investment at certain milestones.
Spun out from Oxford’s Department of Chemistry in 2014, OxSyBio is developing a 3D printing platform that can print…
